Levetiracetam - NDC Database (Page 11)
0228-2119 Jan 21, 2009
Levetiracetam 500 mg Oral Tablet by Orchid Healthcare (A Division of Orchid Chemicals and Pharmaceuticals Ltd.)
Levetiracetam 500 mg Oral Tablet by Orchid Healthcare (A Division of Orchid Chemicals and Pharmaceuticals Ltd.)
0228-2120 Jan 21, 2009
Levetiracetam 750 mg Oral Tablet by Orchid Healthcare (A Division of Orchid Chemicals and Pharmaceuticals Ltd.)
Levetiracetam 750 mg Oral Tablet by Orchid Healthcare (A Division of Orchid Chemicals and Pharmaceuticals Ltd.)
0378-6300 Sep 25, 2013
Levetiracetam 500 mg 24 Hr Extended Release Tablet by Mylan Pharmaceuticals Inc.
Levetiracetam 500 mg 24 Hr Extended Release Tablet by Mylan Pharmaceuticals Inc.
0378-6301 Sep 25, 2013
Levetiracetam 750 mg 24 Hr Extended Release Tablet by Mylan Pharmaceuticals Inc.
Levetiracetam 750 mg 24 Hr Extended Release Tablet by Mylan Pharmaceuticals Inc.
0517-3605 Feb 21, 2012
Levetiracetam 100 mg/ml Intravenous Injection, Solution by American Regent, Inc.
Levetiracetam 100 mg/ml Intravenous Injection, Solution by American Regent, Inc.
0591-3635 Sep 12, 2011
Levetiracetam 500 mg 24 Hr Extended Release Tablet by Watson Laboratories, Inc.
Levetiracetam 500 mg 24 Hr Extended Release Tablet by Watson Laboratories, Inc.
0591-3699 Sep 12, 2011
Levetiracetam 750 mg 24 Hr Extended Release Tablet by Watson Laboratories, Inc.
Levetiracetam 750 mg 24 Hr Extended Release Tablet by Watson Laboratories, Inc.
0603-4186 Jul 20, 2012
Levetiracetam 500 mg 24 Hr Extended Release Tablet by Qualitest Pharmaceuticals
Levetiracetam 500 mg 24 Hr Extended Release Tablet by Qualitest Pharmaceuticals
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.